6 June 2023
HeiQ Plc
("HeiQ" or "the Company")
Notice of Annual General Meeting
HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, announces that it will hold its annual general meeting ("AGM") at 10am on Thursday 29 June 2023 at the offices of Cenkos Securities at 6-8 Tokenhouse Yard, London, EC2R 7AS.
The Notice of AGM and related proxy forms are available on the Company's website, https://www.heiq.com/investor-relations and have been dispatched to shareholders via the CREST system.
Given that the Company's financial reporting processes and the associated audit for the 12 months ended 31 December 2022 are still in progress, the Company intends to invite shareholders to another meeting to vote on the approval of the Annual Report and related matters as soon as these processes are completed, and the Annual Report is duly published.
The Company will provide an update on its Annual Results 2022 and publication of Annual Report 2022 as soon as it is in a position to do so. An in-depth update on strategy and 2023 trading will be provided together with the publication of the Annual Report 2022.
For further information, please contact:
| HeiQ Plc Carlo Centonze (CEO) | +41 56 250 68 50 |
| Cenkos Securities plc (Broker) Stephen Keys / Callum Davidson | +44 (0) 207 397 8900 |
| SEC Newgate (Media Enquiries) Elisabeth Cowell / Molly Gretton | +44 (0) 20 3757 6882 |
About HeiQ
HeiQ is a Swiss-based international company that innovates pioneering and differentiating materials in partnership with established global brands. We bridge the academic and commercial worlds to conceive performance-enhancing materials and technologies, working with aligned brands to research, manufacture and bring products to market, aiming for lab to consumer in months. Our goal is to improve the lives of billions by innovating the materials that go into everyday products, making them more hygienic, comfortable, protective, and sustainable.
Our strong IP portfolio positions us as an innovation leader for niche, premium and high-margin products in the textile chemicals, man-made fibers, paints and coatings, antimicrobial plastics, probiotics and household cleaner markets. We have also expanded into healthcare facilities, probiotic cleaning, and hygiene coatings markets to help make hospitals and healthcare environments more hygienic.
We have developed over 200 technologies in partnership with 300 major brands. With a substantial research and development pipeline, including key technology development projects HeiQ AeoniQ, HeiQ ECOS, HeiQ GrapheneX, and HeiQ Synbio, HeiQ aims to deliver shareholder value through sales growth and entry into new lucrative markets through disruptive innovation and M&A.
We have built a strong reputation for ESG & sustainable innovation, having won multiple awards including the Swiss Technology Award twice and the Swiss Environmental Award. Under experienced leadership, we are committed to driving our profit in close connection with people and the planet. For more information, please visit www.heiq.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.